Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (72 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by Rumpl3StiltSkin on Oct 24, 2023 4:52pm

Poppycock!

There is nothing in the last three press releases that suggest any extra time is needed for BTD/preBTD.
Other than compiling data for this resubmission, which TLT might have done already, I see nothing in either release to suggest that BTD will be delayed significantly. The submission of preBTD approval only takes a few working days, usually. The FDA wanted this data in a certain way and TLT is doing/done that. Everyone needs to relax They have the funds now to get to an AA. :-)
Comment by Longholder99 on Oct 24, 2023 4:59pm
I agree.  Is why I bought more today.  Sp will come back as we move fwd
Comment by N0taP00p on Oct 24, 2023 5:41pm
I very strongly suspect you'll be playing the sad violin before too long and making a different excuse.  Looking forward to your thoughts once they actually tell us the new submission date. End of Q3 and early Q4 have come and gone. All we have is more phase 2 optimization needed and in addition, collection of more >450 day data.  Unclear if one or both needed after reading the NR ...more  
Comment by Rumpl3StiltSkin on Oct 24, 2023 5:45pm
Says who? The crew with the large short position?? Lol!!!
Comment by N0taP00p on Oct 24, 2023 5:55pm
Sorry buddy. Wrong tree to bark up. . But if it gives you comfort to throw that term around rather than come back with better arguments, have at it. The science is great. I wish it was in better hands, preferably in the US.  I keep convincing myself to hold just a bit longer.  It's been a dozen years. That's on me. 
Comment by Infinity on Oct 24, 2023 7:31pm
Hey Poop,  I think you have a valid point that The science is great it is in wrong hands,   the time-lines were not communicated as accurately in the past.  Granted, a biotech start up has many hurdles and most companies fail in the end.  I have not met RDW in person.  I would very much like to attend the next AGM to get a real feel of this company and RDW.  ...more  
Comment by N0taP00p on Oct 24, 2023 8:21pm
Appreciate your thoughts, Infinity. I'm holding for now as well. What choice do we have after so many years. Best.
Comment by StevenBirch on Oct 24, 2023 9:15pm
It's funny, my takeaway from the second last news release where HC granted a CTA-A for the optimization of Phase II so that patients could receive a maintenance treatment was a further positive signal about the safety of the drug/treatment. People here always mentioned the possibility of extra treatments to possibly trigger a response. Dr. Mandel says TLT looks forward to sharing additional ...more  
Comment by Rumpl3StiltSkin on Oct 24, 2023 9:48pm
I'm clearly not as smart as those guys.In fact I'm such a dolt those 3.5c warrants are lookin tasty. Maybe I'll dbl up again. :-)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250